JACLYN BONDHUS: Open Payments
NPI 1548763048 · GRANTS PASS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,222 in 113 payments from 17 companies in 2025. Trend: 2023 $1,722 · 2024 $1,582 · 2025 $2,222
Food & beverage: $2,117Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $365 |
| Galderma Laboratories, L.P. | 11 | $236 |
| Janssen Biotech, Inc. | 8 | $228 |
| UCB, Inc. | 7 | $201 |
| Novartis Pharmaceuticals Corporation | 12 | $186 |
| GENZYME CORPORATION | 7 | $160 |
| E.R. Squibb & Sons, L.L.C. | 5 | $158 |
| PFIZER INC. | 17 | $154 |
| Regeneron Healthcare Solutions, Inc. | 7 | $147 |
| Organon LLC | 11 | $107 |
Products named: DUPIXENT, NEMLUVIO, TREMFYA, SKYRIZI, Bimzelx, Sotyktu, CIBINQO, COSENTYX.
Industry payments across OR — which companies pay providers there.
